After a Nationwide Outbreak of EV-D68 in 2014, the CDC Suggests Caution When Treating Children for Respiratory Disease

In 2014 the U.S. experienced a nationwide outbreak of EV-D68, raising concerns about children’s respiratory health. Acute flaccid myelitis disease (AFM) also spiked. EV-D68 is defined as a group of…

Continue Reading After a Nationwide Outbreak of EV-D68 in 2014, the CDC Suggests Caution When Treating Children for Respiratory Disease

 Mitochondrial Dysfunction is Identified by Researchers Seeking a Common Denominator for Gene Mutations Believed to Cause ALS

Researchers at the UK Dementia Institute in London (UK DRI) have identified a common denominator for various gene mutations that cause amyotrophic lateral sclerosis (ALS). A new CRISPR study shed…

Continue Reading  Mitochondrial Dysfunction is Identified by Researchers Seeking a Common Denominator for Gene Mutations Believed to Cause ALS

Dancing Through Diagnosis: Alnylam’s Givlaari Campaign Puts Rare Disease in the Spotlight

Alnylam Pharmaceuticals has launched a unique promotional campaign for Givlaari, its treatment for acute hepatic porphyria (AHP), that swaps the usual clinical narratives for something more artistic: dance. As reported…

Continue Reading Dancing Through Diagnosis: Alnylam’s Givlaari Campaign Puts Rare Disease in the Spotlight

World’s First Personalized Gene-Editing Therapy Offers Hope to Infant with Rare Disease

In a groundbreaking medical achievement, physicians have administered the world’s first personalized gene-editing therapy to an infant suffering from a rare and fatal genetic disorder. The innovative treatment, described at…

Continue Reading World’s First Personalized Gene-Editing Therapy Offers Hope to Infant with Rare Disease